
Advanced Biomed
(NASDAQ) ADVB
Advanced Biomed Financials at a Glance
Market Cap
$7.45M
Revenue (TTM)
$0.00
Net Income (TTM)
-$677.61K
EPS (TTM)
$0.16
P/E Ratio
28.33
Dividend
$0.00
Beta (Volatility)
0.23 (Low)
Dividend
$0.00
Beta (Volatility)
0.23 (Low)
Price
$4.77
Volume
115
Open
$4.61
Price
$4.77
Volume
115
Open
$4.61
Previous Close
$4.77
Daily Range
$4.46 - $4.79
52-Week Range
$3.61 - $18.20
Estimated Earnings Date
May 15, 2025
Dividend
$0.00
Beta (Volatility)
0.23 (Low)
Price
$4.77
Volume
115
Open
$4.61
Previous Close
$4.77
Daily Range
$4.46 - $4.79
52-Week Range
$3.61 - $18.20
Estimated Earnings Date
May 15, 2025
ADVB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Advanced Biomed
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
31
CEO
Yi Lu, PhD
Website
www.advanbiomed.comHeadquarters
New York City, NY 10168, US
ADVB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
85%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
3.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.45M
Shares Outstanding
1.65M
Volume
115
Avg. Volume
447.97K
Financials (TTM)
Gross Profit
-$10.71K
Operating Income
-$94.11K
EBITDA
-$83.40K
Operating Cash Flow
-$181.46K
Capital Expenditure
-$985.00
Free Cash Flow
-$182.45K
Cash & ST Invst.
$2.90M
Total Debt
$1.26M
Advanced Biomed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$294.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$7.45M
N/A
Market Cap/Employee
$186.28K
N/A
Employees
40
N/A
Net Income
-$488.94K
+64.7%
EBITDA
-$479.50K
+9.3%
Quarterly Fundamentals
Total Cash
$81.41K
-47.9%
Total Debt
$23.20K
-87.6%
Accounts Receivable
$3.02K
-53.3%
Inventory
$0.00
N/A
Long Term Debt
$341.04
-99.2%
Short Term Debt
$41.47K
-70.9%
Return on Assets
-2.03%
N/A
Return on Invested Capital
-3.80%
N/A
Free Cash Flow
-$6.93K
+99.8%
Operating Cash Flow
-$6.90K
+99.8%